MAPT and Alzheimer disease: These blood-based biomarkers for AD include Aβ42/Aβ40 ratio [10], p-tau 181 [11], p-tau 217 [77], p-tau 231 [78], neurofilament light protein (NfL) [12], and glial fibrillary acidic protein (GFAP) [13].